{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:24:12Z","timestamp":1786987452437,"version":"build-2736575974"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.critrevonc.2019.04.005","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T11:47:40Z","timestamp":1555415260000},"page":"156-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas"],"prefix":"10.1016","volume":"138","author":[{"given":"Guido","family":"Carloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Fioretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ponzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.critrevonc.2019.04.005_bib0005","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2019.04.005_bib0010","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S1590-8658(07)80015-6","article-title":"Hepatitis C virus core protein enhances B lymphocyte proliferation","volume":"39","author":"Alisi","year":"2007","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jcp.21211","article-title":"Involvement of PI3K in HCV-related lymphoproliferative disorders","volume":"214","author":"Alisi","year":"2008","journal-title":"J. Cell. Physiol."},{"issue":"6769","key":"10.1016\/j.critrevonc.2019.04.005_bib0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/s10165-011-0565-x","article-title":"Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis","volume":"22","author":"Antonelli","year":"2012","journal-title":"Mod. Rheumatol."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.04.005_bib0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3324\/haematol.2014.116855","article-title":"The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection","volume":"100","author":"Arcaini","year":"2015","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.critrevonc.2019.04.005_bib0040","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2016-05-714667","article-title":"Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection","volume":"128","author":"Arcaini","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.005_bib0045","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jclinpath-2014-202352","article-title":"MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma","volume":"67","author":"Augello","year":"2014","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tim.2010.11.005","article-title":"Assembly of infectious hepatitis C virus particles","volume":"19","author":"Bartenschlager","year":"2011","journal-title":"Trends Microbiol."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13547500701674063","article-title":"Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review","volume":"13","author":"Bien","year":"2008","journal-title":"Biomarkers"},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0065","first-page":"49","article-title":"Animal models for hepatitis C","volume":"369","author":"Billerbeck","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"7053","key":"10.1016\/j.critrevonc.2019.04.005_bib0070","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection","volume":"436","author":"Bowen","year":"2005","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.critrevonc.2019.04.005_bib0075","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jprot.2010.03.010","article-title":"Proteomic analysis of B-cell malignancies","volume":"73","author":"Boyd","year":"2010","journal-title":"J. Proteomics"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/hep.510280127","article-title":"Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice","volume":"28","author":"Bronowicki","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2017.128","article-title":"Chimeric antigen receptor T-cell therapies for lymphoma","author":"Brudno","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0090","first-page":"3","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"3","author":"Cacoub","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"11","key":"10.1016\/j.critrevonc.2019.04.005_bib0095","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0100","doi-asserted-by":"crossref","first-page":"e0156384","DOI":"10.1371\/journal.pone.0156384","article-title":"In situ hepatitis C NS3 protein detection is associated with high grade features in hepatitis C-associated B-cell non-Hodgkin lymphomas","volume":"11","author":"Canioni","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.critrevonc.2019.04.005_bib0105","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.174.10.6532","article-title":"Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis","volume":"174","author":"Carbonari","year":"2005","journal-title":"J. Immunol."},{"issue":"44","key":"10.1016\/j.critrevonc.2019.04.005_bib0110","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.3748\/wjg.v19.i44.7874","article-title":"Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment","volume":"19","author":"Carbone","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"5053","key":"10.1016\/j.critrevonc.2019.04.005_bib0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1373518","article-title":"CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes","volume":"256","author":"Carter","year":"1992","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.005_bib0120","doi-asserted-by":"crossref","first-page":"e18933","DOI":"10.1371\/journal.pone.0018933","article-title":"Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0125","doi-asserted-by":"crossref","first-page":"13882","DOI":"10.1038\/ncomms13882","article-title":"Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"issue":"4902","key":"10.1016\/j.critrevonc.2019.04.005_bib0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ijc.11303","article-title":"Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma","volume":"107","author":"Chung","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.critrevonc.2014.07.004","article-title":"Reproductive factors and non-Hodgkin lymphoma: a systematic review","volume":"92","author":"Costas","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1084\/jem.161.1.88","article-title":"Rheumatoid factor (RF) production during anamnestic immune responses in the mouse. III. Activation of RF precursor cells is induced by their interaction with immune complexes and carrier-specific helper T cells","volume":"161","author":"Coulie","year":"1985","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/annonc\/mdx635","article-title":"From hepatitis C virus infection to B-cell lymphoma","volume":"29","author":"Couronne","year":"2018","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.04.005_bib0155","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/1389450116666150213111603","article-title":"Steps and routes of HCV infection: the great promise of new anti-viral targets","volume":"16","author":"Crema","year":"2015","journal-title":"Curr. Drug Targets"},{"issue":"Pt 10","key":"10.1016\/j.critrevonc.2019.04.005_bib0160","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1099\/0022-1317-76-10-2485","article-title":"In vitro infection of peripheral blood mononuclear cells by hepatitis C virus","volume":"76","author":"Cribier","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0165","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818759483","article-title":"Host-targeting therapies for hepatitis C virus infection: current developments and future applications","volume":"11","author":"Crouchet","year":"2018","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0170","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0168-8278(03)00075-8","article-title":"Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver","volume":"38","author":"Curry","year":"2003","journal-title":"J. Hepatol."},{"issue":"23","key":"10.1016\/j.critrevonc.2019.04.005_bib0175","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1038\/onc.2015.364","article-title":"Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders","volume":"35","author":"Dai","year":"2016","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5501\/wjv.v1.i6.162","article-title":"Hepatitis viruses and non-Hodgkin's lymphoma: a review","volume":"1","author":"Datta","year":"2012","journal-title":"World J. Virol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1097-0215(20000715)87:2<211::AID-IJC9>3.0.CO;2-8","article-title":"Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process","volume":"87","author":"De Re","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2019.04.005_bib0190","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V96.10.3578","article-title":"Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia","volume":"96","author":"De Re","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0195","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.leu.2404201","article-title":"HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations","volume":"20","author":"De Re","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0200","doi-asserted-by":"crossref","first-page":"623465","DOI":"10.1155\/2012\/623465","article-title":"Molecular signature in HCV-positive lymphomas","volume":"2012","author":"De Re","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0205","doi-asserted-by":"crossref","first-page":"e0117420","DOI":"10.1371\/journal.pone.0117420","article-title":"Genetic diversity of the KIR\/HLA system and susceptibility to hepatitis C virus-related diseases","volume":"10","author":"De Re","year":"2015","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.critrevonc.2019.04.005_bib0210","doi-asserted-by":"crossref","first-page":"37487","DOI":"10.18632\/oncotarget.9303","article-title":"HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2","volume":"7","author":"De Re","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.autrev.2008.05.005","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?","volume":"8","author":"De Vita","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1074\/mcp.M111.015362","article-title":"Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles","volume":"11","author":"Deeb","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.gastro.2006.04.016","article-title":"Clinical and therapeutic implications of hepatitis C virus compartmentalization","volume":"131","author":"Di Liberto","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0230","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/JVI.02516-15","article-title":"Specialization of hepatitis C virus envelope glycoproteins for B lymphocytes in chronically infected patients","volume":"90","author":"Douam","year":"2015","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0235","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.20087","article-title":"Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes","volume":"39","author":"Ducoulombier","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0240","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ijc.11254","article-title":"Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis","volume":"106","author":"Edamoto","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"5464","key":"10.1016\/j.critrevonc.2019.04.005_bib0245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.critrevonc.2019.04.005_bib0250","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-06-0154","article-title":"Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma","volume":"12","author":"Feldmann","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.04.005_bib0255","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood.V82.12.3701.3701","article-title":"Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia","volume":"82","author":"Ferri","year":"1993","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0260","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2141.1994.tb05036.x","article-title":"Hepatitis C virus infection in patients with non-Hodgkin's lymphoma","volume":"88","author":"Ferri","year":"1994","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4254\/wjh.v7.i3.327","article-title":"Hepatitis C virus syndrome: a constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer","volume":"7","author":"Ferri","year":"2015","journal-title":"World J. Hepatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0270","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1084\/jem.178.5.1473","article-title":"Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes","volume":"178","author":"Fluckiger","year":"1993","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0275","doi-asserted-by":"crossref","first-page":"e62965","DOI":"10.1371\/journal.pone.0062965","article-title":"Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia","volume":"8","author":"Fognani","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0280","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1172\/JCI115368","article-title":"Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C","volume":"88","author":"Fong","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0285","doi-asserted-by":"crossref","first-page":"807351","DOI":"10.1155\/2012\/807351","article-title":"Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis","volume":"2012","author":"Forghieri","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"Pt 10","key":"10.1016\/j.critrevonc.2019.04.005_bib0290","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1099\/0022-1317-79-10-2367","article-title":"In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus","volume":"79","author":"Fournier","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0295","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2249.1994.tb06584.x","article-title":"Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia","volume":"97","author":"Gabrielli","year":"1994","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0300","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/infdis\/171.3.672","article-title":"Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C","volume":"171","author":"Galli","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2019.04.005_bib0305","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/sj.cdd.4401121","article-title":"Hepatitis C virus biology","volume":"10","author":"Giannini","year":"2003","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.critrevonc.2019.04.005_bib0310","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1182\/blood-2008-07-170613","article-title":"Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?","volume":"112","author":"Giannini","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0315","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2036.2005.02395.x","article-title":"Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection","volume":"21","author":"Gisbert","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0320","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cancergencyto.2007.09.009","article-title":"Random aneuploidy in chronic hepatitis C patients","volume":"180","author":"Goldberg-Bittman","year":"2008","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-3527(08)00002-X","article-title":"Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems","volume":"71","author":"Gottwein","year":"2008","journal-title":"Adv. Virus Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0330","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.chom.2008.05.002","article-title":"Viral and cellular microRNAs as determinants of viral pathogenesis and immunity","volume":"3","author":"Gottwein","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0335","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/art.30274","article-title":"Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcgamma receptors","volume":"63","author":"Gragnani","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"1 Suppl","key":"10.1016\/j.critrevonc.2019.04.005_bib0340","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0345","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.04.005_bib0350","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2893.2006.00833.x","article-title":"Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases","volume":"14","author":"Hofmann","year":"2007","journal-title":"J. Viral Hepat."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0355","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.virol.2004.11.041","article-title":"Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2","volume":"332","author":"Hu","year":"2005","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0360","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0002-9440(10)65496-X","article-title":"Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection","volume":"155","author":"Huang","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0365","first-page":"1328","article-title":"Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro","volume":"26","author":"Iacovacci","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0370","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0147-9571(02)00038-3","article-title":"Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice","volume":"26","author":"Ishikawa","year":"2003","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0375","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.clim.2010.02.002","article-title":"Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients","volume":"135","author":"Ito","year":"2010","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0380","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.biotechadv.2011.06.020","article-title":"Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge","volume":"30","author":"Iurescia","year":"2012","journal-title":"Biotechnol. Adv."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.04.005_bib0385","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V91.7.2433","article-title":"Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas","volume":"91","author":"Ivanovski","year":"1998","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.critrevonc.2019.04.005_bib0390","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2010-05-283358","article-title":"Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo","volume":"116","author":"Kasama","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0395","doi-asserted-by":"crossref","first-page":"e91373","DOI":"10.1371\/journal.pone.0091373","article-title":"B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-kappaB signalling","volume":"9","author":"Kasama","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0400","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1006\/bbrc.1995.1123","article-title":"Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection","volume":"206","author":"Kato","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.005_bib0405","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1182\/blood.V96.8.2910","article-title":"Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II","volume":"96","author":"Kitay-Cohen","year":"2000","journal-title":"Blood"},{"issue":"Suppl. 19","key":"10.1016\/j.critrevonc.2019.04.005_bib0410","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00535-008-2276-4","article-title":"Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection","volume":"44","author":"Koike","year":"2009","journal-title":"J. Gastroenterol."},{"issue":"44","key":"10.1016\/j.critrevonc.2019.04.005_bib0415","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.3748\/wjg.v19.i44.7889","article-title":"Direct effects of hepatitis C virus on the lymphoid cells","volume":"19","author":"Kondo","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"40","key":"10.1016\/j.critrevonc.2019.04.005_bib0420","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","article-title":"Mechanisms of chromosomal translocations in B cell lymphomas","volume":"20","author":"Kuppers","year":"2001","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.critrevonc.2019.04.005_bib0425","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/jvi.69.12.8079-8083.1995","article-title":"Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR","volume":"69","author":"Lanford","year":"1995","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0430","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0435","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2353\/ajpath.2007.060789","article-title":"Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes","volume":"170","author":"Lazaro","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0440","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1172\/JCI118485","article-title":"Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells","volume":"97","author":"Lerat","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"27","key":"10.1016\/j.critrevonc.2019.04.005_bib0445","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1038\/sj.onc.1209562","article-title":"Viral hepatitis and liver cancer: the case of hepatitis C","volume":"25","author":"Levrero","year":"2006","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.critrevonc.2019.04.005_bib0450","doi-asserted-by":"crossref","first-page":"12531","DOI":"10.1128\/JVI.01136-12","article-title":"Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways","volume":"86","author":"Li","year":"2012","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.04.005_bib0455","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.leu.2402968","article-title":"Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue","volume":"17","author":"Libra","year":"2003","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.critrevonc.2019.04.005_bib0460","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/cbt.4.11.2087","article-title":"Elevated serum levels of osteopontin in HCV-associated lymphoproliferative disorders","volume":"4","author":"Libra","year":"2005","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0465","first-page":"1305","article-title":"Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders","volume":"15","author":"Libra","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0470","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1182\/blood.V124.21.4474.4474","article-title":"Dendritic cell vaccine treatment for B-cell non-Hodgkin lymphoma: clinical trial in progress","volume":"124","author":"Lin","year":"2014","journal-title":"Blood"},{"issue":"5734","key":"10.1016\/j.critrevonc.2019.04.005_bib0475","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0480","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/hep.25642","article-title":"Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon","volume":"56","author":"Liu","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0485","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/jm401401n","article-title":"On the history of hepatitis C virus cell culture systems","volume":"57","author":"Lohmann","year":"2014","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.critrevonc.2019.04.005_bib0490","doi-asserted-by":"crossref","first-page":"12140","DOI":"10.1074\/jbc.M010137200","article-title":"Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins","volume":"276","author":"Machida","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.04.005_bib0495","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"101","author":"Machida","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.critrevonc.2019.04.005_bib0500","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/JVI.79.13.8079-8089.2005","article-title":"Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells","volume":"79","author":"Machida","year":"2005","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.critrevonc.2019.04.005_bib0505","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1128\/JVI.02582-07","article-title":"Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein","volume":"82","author":"Machida","year":"2008","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.critrevonc.2019.04.005_bib0510","doi-asserted-by":"crossref","first-page":"12590","DOI":"10.1128\/JVI.02643-08","article-title":"Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway","volume":"83","author":"Machida","year":"2009","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0515","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.gastro.2009.03.061","article-title":"Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins","volume":"137","author":"Machida","year":"2009","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.critrevonc.2019.04.005_bib0520","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.4049\/jimmunol.1000618","article-title":"Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1\/Mre11\/Rad50 DNA repair pathway in monocytes and hepatocytes","volume":"185","author":"Machida","year":"2010","journal-title":"J. Immunol."},{"issue":"Pt 12","key":"10.1016\/j.critrevonc.2019.04.005_bib0525","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1099\/vir.0.81868-0","article-title":"De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro","volume":"87","author":"MacParland","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0530","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/cdli.1.2.160-163.1994","article-title":"Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients","volume":"1","author":"Manzin","year":"1994","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0535","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)61691-4","article-title":"Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma","volume":"159","author":"Marasca","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0540","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2010-06-275818","article-title":"Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities","volume":"117","author":"Marcucci","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0545","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1128\/jvi.66.5.3225-3229.1992","article-title":"Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution","volume":"66","author":"Martell","year":"1992","journal-title":"J. Virol."},{"issue":"26","key":"10.1016\/j.critrevonc.2019.04.005_bib0550","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.1073\/pnas.1301764110","article-title":"Identification of transferrin receptor 1 as a hepatitis C virus entry factor","volume":"110","author":"Martin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.005_bib0555","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.178.4.1407","article-title":"Functional dissection of the CD21\/CD19\/TAPA-1\/Leu-13 complex of B lymphocytes","volume":"178","author":"Matsumoto","year":"1993","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0560","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0565","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0570","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2893.2010.01367.x","article-title":"Genetic recombination of the hepatitis C virus: clinical implications","volume":"18","author":"Morel","year":"2011","journal-title":"J. Viral Hepat."},{"issue":"9","key":"10.1016\/j.critrevonc.2019.04.005_bib0575","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Moriya","year":"1998","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0580","first-page":"1138","article-title":"Replication of hepatitis C virus in B lymphocytes (CD19+)","volume":"94","author":"Morsica","year":"1999","journal-title":"Blood"},{"issue":"Pt 4","key":"10.1016\/j.critrevonc.2019.04.005_bib0585","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1099\/0022-1317-74-4-669","article-title":"Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication","volume":"74","author":"Muller","year":"1993","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0590","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.510300107","article-title":"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C","volume":"30","author":"Murakami","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0595","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jmv.2204","article-title":"Dendritic cell susceptibility to hepatitis C virus genotype 1 infection","volume":"67","author":"Navas","year":"2002","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.critrevonc.2019.04.005_bib0600","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2013-10-532895","article-title":"B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.005_bib0605","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/icb.2010.121","article-title":"PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma","volume":"89","author":"Ni","year":"2011","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0610","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1053\/j.gastro.2006.09.019","article-title":"Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH","volume":"131","author":"Nieters","year":"2006","journal-title":"Gastroenterology"},{"issue":"52","key":"10.1016\/j.critrevonc.2019.04.005_bib0615","doi-asserted-by":"crossref","first-page":"36442","DOI":"10.1074\/jbc.M109.043232","article-title":"Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase","volume":"284","author":"Nishimura","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0620","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.2005.02.7938","article-title":"Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders","volume":"24","author":"Novak","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0625","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B-cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0630","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.chom.2014.10.008","article-title":"Hepatitis C virus RNA replication and assembly: living on the fat of the land","volume":"16","author":"Paul","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0635","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.critrevonc.2014.10.008","article-title":"Hepatitis C virus and lymphoma","volume":"93","author":"Paydas","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0640","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.29364","article-title":"Efficacy and safety of new direct antiviral agents in hepatitis C virus-infected patients with diffuse large B-cell non-Hodgkin's lymphoma","volume":"67","author":"Persico","year":"2018","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.critrevonc.2019.04.005_bib0645","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/leu.2012.29","article-title":"Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection","volume":"26","author":"Peveling-Oberhag","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0650","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0655","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coviro.2016.09.004","article-title":"Viral evasion and challenges of hepatitis C virus vaccine development","volume":"20","author":"Pierce","year":"2016","journal-title":"Curr. Opin. Virol."},{"issue":"5390","key":"10.1016\/j.critrevonc.2019.04.005_bib0660","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0665","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coviro.2011.12.007","article-title":"Hepatitis C virus host cell entry","volume":"2","author":"Ploss","year":"2012","journal-title":"Curr. Opin. Virol."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.005_bib0670","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1053\/j.gastro.2010.06.058","article-title":"Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes","volume":"139","author":"Podevin","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0675","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/hep.28580","article-title":"Hepatitis C virus and lymphoma","volume":"64","author":"Ponzetto","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0680","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4254\/wjh.v8.i2.107","article-title":"Hepatitis C virus and non-Hodgkin's lymphomas: meta-analysis of epidemiology data and therapy options","volume":"8","author":"Pozzato","year":"2016","journal-title":"World J. Hepatol."},{"issue":"13","key":"10.1016\/j.critrevonc.2019.04.005_bib0685","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","article-title":"The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis","volume":"98","author":"Quinn","year":"2001","journal-title":"Blood"},{"issue":"32","key":"10.1016\/j.critrevonc.2019.04.005_bib0690","doi-asserted-by":"crossref","first-page":"13109","DOI":"10.1073\/pnas.1221899110","article-title":"Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells","volume":"110","author":"Ramakrishnaiah","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0695","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0168-8278(00)00063-5","article-title":"High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders","volume":"34","author":"Realdon","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0700","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1743-422X-8-346","article-title":"Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence","volume":"8","author":"Revie","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0705","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1743-422X-2-37","article-title":"Transmission of human hepatitis C virus from patients in secondary cells for long term culture","volume":"2","author":"Revie","year":"2005","journal-title":"Virol. J."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0710","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbrc.2008.03.076","article-title":"Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model","volume":"370","author":"Rinaldi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0715","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/nar\/gkt841","article-title":"End-to-end crosstalk within the hepatitis C virus genome mediates the conformational switch of the 3\u2019X-tail region","volume":"42","author":"Romero-Lopez","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.005_bib0720","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/jvh.12526","article-title":"Lymphomagenesis-related gene expression in B cells from sustained virological responders with occult hepatitis C virus infection","volume":"23","author":"Roque Cuellar","year":"2016","journal-title":"J. Viral Hepat."},{"issue":"51","key":"10.1016\/j.critrevonc.2019.04.005_bib0725","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0730","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1309\/2JK279BU2G743MWJ","article-title":"miRNA: the new gene silencer","volume":"128","author":"Ross","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0735","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1479-5876-12-207","article-title":"Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice","volume":"12","author":"Ruffini","year":"2014","journal-title":"J. Transl. Med."},{"issue":"Pt 11","key":"10.1016\/j.critrevonc.2019.04.005_bib0740","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1099\/0022-1317-80-11-3007","article-title":"Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro","volume":"80","author":"Rumin","year":"1999","journal-title":"J. Gen. Virol."},{"issue":"9","key":"10.1016\/j.critrevonc.2019.04.005_bib0745","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/art.21270","article-title":"Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy","volume":"52","author":"Saadoun","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0750","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0755","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/hep.20887","article-title":"HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation","volume":"42","author":"Sansonno","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0760","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2008-02-137455","article-title":"Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis","volume":"112","author":"Sansonno","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2019.04.005_bib0765","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.06956-11","article-title":"Hepatitis C virus infection of human T lymphocytes is mediated by CD5","volume":"86","author":"Sarhan","year":"2012","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0770","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.173.5.3549","article-title":"Frequent joining of Bcl-2 to a JH6 gene in hepatitis C virus-associated t(14;18)","volume":"173","author":"Sasso","year":"2004","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.critrevonc.2019.04.005_bib0775","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.3390\/v4112924","article-title":"Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)","volume":"4","author":"Sautto","year":"2012","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.critrevonc.2019.04.005_bib0780","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1086\/592986","article-title":"Frequent compartmentalization of hepatitis C virus with leukocyte-related amino acids in the setting of liver transplantation","volume":"198","author":"Schramm","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"26","key":"10.1016\/j.critrevonc.2019.04.005_bib0785","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.04.005_bib0790","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1073\/pnas.89.12.5477","article-title":"Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line","volume":"89","author":"Shimizu","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.critrevonc.2019.04.005_bib0795","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1128\/JVI.76.18.9345-9354.2002","article-title":"Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model","volume":"76","author":"Soguero","year":"2002","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0800","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1182\/blood-2008-05-158824","article-title":"Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells","volume":"113","author":"Stamataki","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0805","first-page":"17","article-title":"Cell culture systems for hepatitis C virus","volume":"369","author":"Steinmann","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0810","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/hep.28387","article-title":"Hepatitis C viral infection increases the risk of lymphoid-neoplasms: a population-based cohort study","volume":"63","author":"Su","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0815","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JVI.77.3.2134-2146.2003","article-title":"Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection","volume":"77","author":"Sung","year":"2003","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.04.005_bib0820","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1172\/JCI72415","article-title":"Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression","volume":"124","author":"Sungalee","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.critrevonc.2019.04.005_bib0825","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/1097-0142(19921101)70:9<2255::AID-CNCR2820700907>3.0.CO;2-N","article-title":"Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus-strand and minus-strand viral RNA","volume":"70","author":"Takeda","year":"1992","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.critrevonc.2019.04.005_bib0830","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1128\/JVI.00753-07","article-title":"Studying hepatitis C virus: making the best of a bad virus","volume":"81","author":"Tellinghuisen","year":"2007","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0835","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.autrev.2013.11.001","article-title":"Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection","volume":"13","author":"Terrier","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0840","doi-asserted-by":"crossref","first-page":"167501","DOI":"10.5402\/2011\/167501","article-title":"Hepatitis C virus-related lymphomagenesis in a mouse model","volume":"2011","author":"Tsukiyama-Kohara","year":"2011","journal-title":"ISRN Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0845","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/JVI.03081-12","article-title":"B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes","volume":"87","author":"Tucci","year":"2013","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.005_bib0850","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0923-2516(96)80573-5","article-title":"Detection of a 5\u2032 UTR variation in the HCV genome after a long-term in vitro infection","volume":"146","author":"Valli","year":"1995","journal-title":"Res. Virol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0855","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jmv.20527","article-title":"Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact","volume":"78","author":"Valli","year":"2006","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0860","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/2040620715623924","article-title":"Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?","volume":"7","author":"Vannata","year":"2016","journal-title":"Ther. Adv. Hematol."},{"issue":"32","key":"10.1016\/j.critrevonc.2019.04.005_bib0865","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.3748\/wjg.v20.i32.11054","article-title":"Hepatitis C virus and diffuse large B-cell lymphoma: pathogenesis, behavior and treatment","volume":"20","author":"Visco","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.critrevonc.2019.04.005_bib0870","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/bjc.2017.345","article-title":"Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations","volume":"117","author":"Visco","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0875","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.critrevonc.2019.04.005_bib0880","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm.3391","article-title":"Tumor metastasis: moving new biological insights into the clinic","volume":"19","author":"Wan","year":"2013","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0885","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/infdis\/166.5.1167","article-title":"Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells","volume":"166","author":"Wang","year":"1992","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0890","first-page":"1089","article-title":"Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice","volume":"144","author":"Wasik","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"19","key":"10.1016\/j.critrevonc.2019.04.005_bib0895","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM198711053171904","article-title":"Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas","volume":"317","author":"Weiss","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.04.005_bib0900","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/1042819031000076972","article-title":"Hepatitis C virus (HCV) and lymphomagenesis","volume":"44","author":"Weng","year":"2003","journal-title":"Leuk. Lymphoma"},{"issue":"1 Suppl","key":"10.1016\/j.critrevonc.2019.04.005_bib0905","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J. Hepatol."},{"issue":"1\u20133","key":"10.1016\/j.critrevonc.2019.04.005_bib0910","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2119\/2006-00020.Wu","article-title":"Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes","volume":"12","author":"Wu","year":"2006","journal-title":"Mol. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.005_bib0915","doi-asserted-by":"crossref","first-page":"e1002617","DOI":"10.1371\/journal.ppat.1002617","article-title":"Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation","volume":"8","author":"Wu","year":"2012","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.005_bib0920","doi-asserted-by":"crossref","first-page":"e0146624","DOI":"10.1371\/journal.pone.0146624","article-title":"Proteomics based identification of proteins with deregulated expression in B cell lymphomas","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0925","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/JVI.00688-11","article-title":"Activation of the Ras\/Raf\/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway","volume":"86","author":"Zhang","year":"2012","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.005_bib0930","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1128\/JVI.72.5.3691-3697.1998","article-title":"Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis","volume":"72","author":"Zhu","year":"1998","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0935","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0168-8278(92)90073-X","article-title":"Infection of peripheral mononuclear blood cells by hepatitis C virus","volume":"15","author":"Zignego","year":"1992","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.005_bib0940","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s007050050100","article-title":"Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role","volume":"142","author":"Zignego","year":"1997","journal-title":"Arch. Virol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0945","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.510310230","article-title":"T(14;18) translocation in chronic hepatitis C virus infection","volume":"31","author":"Zignego","year":"2000","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.critrevonc.2019.04.005_bib0950","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann. Intern. Med."},{"issue":"17","key":"10.1016\/j.critrevonc.2019.04.005_bib0955","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3748\/wjg.v13.i17.2467","article-title":"Hepatitis C virus-related lymphoproliferative disorders: an overview","volume":"13","author":"Zignego","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.critrevonc.2019.04.005_bib0960","doi-asserted-by":"crossref","first-page":"980942","DOI":"10.1155\/2012\/980942","article-title":"HCV and lymphoproliferation","volume":"2012","author":"Zignego","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.005_bib0965","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2141.2001.02573.x","article-title":"bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection","volume":"112","author":"Zuckerman","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.005_bib0970","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood.V97.6.1555.h8001555_1555_1559","article-title":"The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection","volume":"97","author":"Zuckerman","year":"2001","journal-title":"Blood"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842818304979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842818304979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:30:15Z","timestamp":1760902215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842818304979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":194,"alternative-id":["S1040842818304979"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.005","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}